Journal for ImmunoTherapy of Cancer (Nov 2020)

390 Emerging safety and activity data from GEN-009–101: A phase 1/2a trial of GEN-009, a neoantigen vaccine in combination with PD-1 check-point inhibitors (CPI) in advanced solid tumors

  • Thomas Davis,
  • Jessica Price,
  • Ammar Sukari,
  • Roger Cohen,
  • Przemyslaw Twardowski,
  • Jessica Flechtner,
  • Melissa Johnson,
  • Maura Gillison,
  • Rudy Lackner,
  • Arthur DeCillis,
  • Richard Hernandez,
  • Kevin Mancini,
  • Mara Shainheit

DOI
https://doi.org/10.1136/jitc-2020-SITC2020.0390
Journal volume & issue
Vol. 8, no. Suppl 3

Abstract

Read online

No abstracts available.